NOMAD POWER SOLUTIONS, INC. Number of Reportable Segments
NOMAD POWER SOLUTIONS, INC. (NMAD) reported Number of Reportable Segments of 1 Segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes
us-gaap:NumberOfReportableSegments · last filed 2026-08-14
- NOMAD POWER SOLUTIONS, INC. number of reportable segments for the quarter ending 2026-03-31 was 1.00 Segment.
- NOMAD POWER SOLUTIONS, INC. number of reportable segments for fiscal 2023 was 1.00 Segment.
Segment
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 Segment 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | 1.00 Segment 10-Q · filed 2026-05-14 | |||
| 2025-09-30 | 1.00 Segment 10-Q · filed 2025-11-12 | |||
| 2023-12-31 | 1.00 Segment 10-K · filed 2024-03-19 |
Integer
| Period end | Number of Reportable Segments 12 month |
|---|---|
| 2025-12-31 | 1.00 Integer 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |